Cardiovascular effects of melatonin in hypertensive patients well controlled by nifedipine: a 24‐hour study
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Aims As melatonin has been found to play a role in the mechanisms of cardiovascular regulation, we designed the present study to evaluate whether the evening ingestion of the pineal hormone might interfere with the antihypertensive therapy in hypertensive patients well‐controlled by nifedipine monotherapy. Methods Forty‐seven mild to moderate essential hypertensive outpatients taking nifedipine GITS 30 or 60 mg monotherapy at 08.30 h for at least 3 months, were given placebo or melatonin 5 mg at 22.30 h for 4 weeks according to a double‐blind cross‐over study. At the end of each treatment period patients underwent a 24 h noninvasive ambulatory blood pressure monitoring (ABPM) during usual working days; sleeping period was scheduled to last from 23.00 to 07.00 h. Results The evening administration of melatonin induced an increase of blood pressure and heart rate throughout the 24 h period (ΔSBP = + 6.5 mmHg, P < 0.001; ΔDBP = + 4.9 mmHg, P < 0.01; ΔHR = + 3.9 beats min−1, P < 0.01). The DBP as well as the HR increase were particularly evident during the morning and the afternoon hours. Conclusions We hypothesize that competition between melatonin and nifedipine, is able to impair the antihypertensive efficacy of the calcium channel blocker. This suggests caution in uncontrolled use of melatonin in hypertensive patients. As the pineal hormone might interfere with calcium channel blocker therapy, it cannot be considered simply a dietary supplement.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Brzezinski, A. (1997) · New England Journal of Medicine · doi:10.1056/nejm199701163360306 · Cited by 1,549
Melatonin Decreases Brain Serotonin Release, Arterial Pressure and Heart Rate in Rats
Chuang, J. I., Chen, S. S., & Lin, M. T. (2008) · Pharmacology · doi:10.1159/000139083 · Cited by 99
Antihypertensive Action of Melatonin in the Spontaneously Hypertensive Rat
Kawashima, K., Miwa, Y., Fujimoto, K., Oohata, H., Nishino, H., & Koike, H. (1987) · Clinical and Experimental Hypertension. Part A: Theory and Practice · doi:10.3109/10641968709160037 · Cited by 75
Pang, C. S., Tang, P. L., Song, Y., Brown, G. M., & Panga, S. F. (1996) · Life Sciences · doi:10.1016/0024-3205(96)00058-6 · Cited by 23
Cited by
The basic physiology and pathophysiology of melatonin
Claustrat, B., Brun, J., & Chazot, G. (2005) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2004.08.001 · Cited by 950
Melatonin membrane receptors in peripheral tissues: Distribution and functions
Slominski, R. M., Reiter, R. J., Schlabritz-Loutsevitch, N., Ostrom, R. S., & Slominski, A. T. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.01.004 · Cited by 675
Hardeland, R. (2005) · Endocrine · doi:10.1385/endo:27:2:119 · Cited by 671
Daily nighttime melatonin reduces blood pressure in male patients with essential hypertension
Scheer, F. A. J. L., Van Montfrans, G. A., van Someren, E. J. W., Mairuhu, G., & Buijs, R. M. (2004) · Hypertension · doi:10.1161/01.hyp.0000113293.15186.3b · Cited by 451
Trends in the development of radioprotective agents
Hosseinimehr, S. J. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2007.07.017 · Cited by 427
Metadata
- Authors
- Lusardi, P., Piazza, E., & Fogari, R.
- Venue
- British Journal of Clinical Pharmacology
- Publisher
- Wiley
- Published
- 2000-05
- Volume
- 49
- Issue
- 5
- Pages
- 423-427
- ISSN
- 0306-5251 (ISSN-L)
- 1365-2125
- OpenAlex
- W2114922149
- Cited by
- 115
- References
- 4
- FWCI
- 1.10
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cardiovascular effects of melatonin in hypertensive patients well controlled by nifedipine: a 24‐hour study. https://app.cochat.ai/papers/10.1046/j.1365-2125.2000.00195.x
- The paper
- Lusardi, P., Piazza, E., & Fogari, R. (2000). Cardiovascular effects of melatonin in hypertensive patients well controlled by nifedipine: a 24‐hour study. British Journal of Clinical Pharmacology. https://doi.org/10.1046/j.1365-2125.2000.00195.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.